Literature DB >> 10357401

Clinical significance of spontaneous apoptosis in advanced gastric adenocarcinoma.

M Ikeguchi1, J Cai, N Yamane, M Maeta, N Kaibara.   

Abstract

BACKGROUND: Spontaneous apoptosis has been detected in gastric carcinoma. However, the clinicopathological significance of this remains unclear. The objective of this study was to investigate the correlation between spontaneous apoptosis and the clinicopathologic and biologic characteristics of advanced gastric carcinoma. In addition, the prognostic significance of spontaneous apoptosis of tumors was evaluated.
METHODS: The occurrence of apoptotic cell death (apoptotic index [AI]) in 97 patients with advanced gastric carcinoma was analyzed by the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate biotin nick end labeling method. The Ki-67 labeling index (LI), expression of p53 and p21, DNA ploidy pattern, microvessel density (MVD), density of dendritic cells (DCs) in tumors, and degree of lymphocytic infiltration (LI) of the tumors were compared with the AI for each patient. In addition, the prognostic significance of AI was evaluated in these patients.
RESULTS: The mean AI of the 97 tumors was 2.05% (range, 0-11.31%). Statistical analyses revealed significant correlations between the AIs and the Ki-67 LIs (P = 0.0004) and between the AIs and the density of DCs (P = 0.0007), as well as an inverse correlation between the AIs and the intratumoral MVD (P = 0.0064). In addition, the AI of 47 tumors with high grade LI (2.94+/-2.51%) was significantly higher than that of 50 tumors with low grade LI (1.22+/-0.93%) (P<0.0001). However, the authors failed to find a significant correlation between the AIs and expression of p53 and p21 and the DNA ploidy pattern. In 93 surviving patients, the 5-year survival rate of 45 patients who had tumors with high AIs (> or =1.47; 82%) was significantly better than that of 48 patients who had tumors with low AIs (<1.47; 60%) (P = 0.0264).
CONCLUSIONS: The findings of the current study suggest that the tumors with low neovascularization and high local immunoreactivity may regulate their progression by apoptosis. Moreover, less extensive apoptosis in gastric adenocarcinoma may contribute to disease progression and could be correlated with a poorer prognosis.

Entities:  

Mesh:

Year:  1999        PMID: 10357401

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Progress in research on applying Sijunzi Decoction in treating digestive malignant tumor.

Authors:  Bin Wu; Zheng-rong Xuan
Journal:  Chin J Integr Med       Date:  2007-06       Impact factor: 1.978

2.  Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.

Authors:  G O Elpek; T Gelen; N H Aksoy; T Karpuzoglu; N Keles
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  The role of SPARC protein expression in the progress of gastric cancer.

Authors:  Lifeng Wang; Miling Yang; Lihui Shan; Lei Qi; Cuicui Chai; Qiufeng Zhou; Ke Yao; Hongmei Wu; Wenguang Sun
Journal:  Pathol Oncol Res       Date:  2012-01-13       Impact factor: 3.201

4.  Inducible nitric oxide synthase, nitrotyrosine and apoptosis in gastric adenocarcinomas and their correlation with a poor survival.

Authors:  Long-Gang Li; Hui-Mian Xu
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

5.  Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index.

Authors:  M Tenderenda; P Rutkowski; D Jesionek-Kupnicka; R Kubiak
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

6.  Effects of Chinese Jianpi herbs on cell apoptosis and related gene expression in human gastric cancer grafted onto nude mice.

Authors:  Ai-Guang Zhao; Hai-Lei Zhao; Xiao-Jie Jin; Jin-Kun Yang; Lai-Di Tang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

7.  Immunohistochemical expression of osteopontin in gastric cancer.

Authors:  Motohiro Imano; Takao Satou; Tatsuki Itoh; Kenichi Sakai; Eizaburo Ishimaru; Atsushi Yasuda; Ying-Feng Peng; Masayuki Shinkai; Fumiharu Akai; Takushi Yasuda; Haruhiko Imamoto; Kiyokata Okuno; Hiroyuki Ito; Hitoshi Shiozaki; Harumasa Ohyanagi
Journal:  J Gastrointest Surg       Date:  2009-07-07       Impact factor: 3.452

8.  Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation.

Authors:  C Sakakura; A Hagiwara; R Yasuoka; Y Fujita; M Nakanishi; K Masuda; K Shimomura; Y Nakamura; J Inazawa; T Abe; H Yamagishi
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.